- Price
- $12.85
- Day
- +3.05%
- Mkt Cap
- $858.77M
- 52W Range
- $4.97 – $20.88
- Volume
- 1.76M
- Beta
- 1.01
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
Rapid7 Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (“Rapid7”) (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, announced that the company granted inducement awards, effective as of September 15, 2026, to employees as a material inducement to commence employment with Rapid7 and its subsidiaries.
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Eli Lilly, Etsy, Lear, Netskope, Nokia, Northrop Grumman, Rapid7, Rivian Automotive, Ulta Beauty, and More
Markets are rattled ahead of Wednesday's Fed decision, and Wall Street analysts are making bold moves on names like Eli Lilly, Etsy, Northrop Grumman, and Rivian. Find out which stocks got upgraded, downgraded, or newly covered before the opening bell.
Hsbc Holdings PLC Purchases 86,623 Shares of Rapid7, Inc. $RPD
Hsbc Holdings PLC boosted its position in Rapid7, Inc. (NASDAQ: RPD) by 252.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 120,946 shares of the technology company's stock after purchasing an additional 86,623 shares during the period.
Rapid7, Inc. (RPD) Presents at Citi's 2026 Global TMT Conference Transcript
Rapid7, Inc. (RPD) Presents at Citi's 2026 Global TMT Conference Transcript
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
Second Rare Pediatric Disease (RPD) Designation for QRX003 FDA Previously Granted RPD Designation for QRX003 in Netherton Syndrome If a New Drug Application (NDA) for QRX003 Is Approved for Peeling Skin Syndrome, Quoin May Receive a Freely Tradable Priority Review Voucher (PRV) Quoin Expects to Initiate Phase 2 Study in 2H 2026; Study Plans to Enroll up to 12 Pediatric and Adult Peeling Skin Patients in the U.S. and Europe There are Currently No Approved Treatments for Peeling Skin Syndrome ASHBURN, Va., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd.